GoldenGolden
Advanced Search
Covagen

Covagen

A biopahramaceutical company developing protein-based therapeutics to treat inflammatory diseases and cancer

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

December 9, 2013
Covagen raises a $47,200,000 series B round from Gimv, MP Healthcare Venture Management, Novartis Venture Fund, Seroba Life Sciences and Ventech.
November 29, 2010
Covagen raises a $6,300,000 series A round from MP Healthcare Venture Management, Novartis Venture Fund and Ventech.

Funding rounds

People

Name
Role
LinkedIn

Karl Nägler

Board member

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.